Transforming growth factor-β1 impairs CFTR-mediated anion secretion across cultured porcine vas deferens epithelial monolayer via the p38 MAPK pathway

American Journal of Physiology - Cell Physiology

Volumn 305, Issue 8, 2013, Pages

  Yi, Sheng ^a   Pierucci Alves, Fernando ^a   Schultz, Bruce D ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

CFTR; Male infertility; P38 MAPK; Tgf 1; Vas deferens epithelial cells

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ANION; ANISOMYCIN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FORSKOLIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DOWN REGULATION; EPITHELIUM CELL; IMMUNOBLOTTING; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SHORT CIRCUIT CURRENT; SIGNAL TRANSDUCTION; SWINE; VAS DEFERENS; WESTERN BLOTTING;

CFTR; MALE INFERTILITY; P38 MAPK; TGF-Β1; VAS DEFERENS EPITHELIAL CELLS;

ANIMALS; ANIONS; ANISOMYCIN; BENZAMIDES; CELLS, CULTURED; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIOXOLES; ENZYME INHIBITORS; EPITHELIAL CELLS; IMIDAZOLES; INFERTILITY, MALE; MALE; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN SYNTHESIS INHIBITORS; PYRIDINES; RNA, MESSENGER; SWINE; TRANSFORMING GROWTH FACTOR BETA1; VAS DEFERENS;

EID: 84885665474     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00121.2013     Document Type: Article

References (50)

1. Arkwright PD, Laurie S, Super M, Pravica V, Schwarz MJ, Webb AK, Hutchinson IV. TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis. Thorax 55: 459-462, 2000.
2. Ballard ST, Trout L, Bebok Z, Sorscher EJ, Crews A. CFTR involvement in chloride, bicarbonate, and liquid secretion by airway submucosal glands. Am J Physiol Lung Cell Mol Physiol 277: L694-L699, 1999.
3. Barros LF, Young M, Saklatvala J, Baldwin SA. Evidence of two mechanisms for the activation of the glucose transporter GLUT1 by anisomycin: p38(MAP kinase) activation and protein synthesis inhibition in mammalian cells. J Physiol 504: 517-525, 1997.
4. Carlin RW, Quesnell RR, Zheng L, Mitchell KE, Schultz BD. Functional and molecular evidence for Na-HCO cotransporter in porcine vas deferens epithelia. Am J Physiol Cell Physiol 283: C1033-C1044, 2002.
5. Carlin RW, Sedlacek RL, Quesnell RR, Pierucci-Alves F, Grieger DM, Schultz BD. PVD9902, a porcine vas deferens epithelial cell line that exhibits neurotransmitter-stimulated anion secretion and expresses numerous HCO3 transporters. Am J Physiol Cell Physiol 290: C1560-C1571, 2006.
6. Chaudhury A, Howe PH. The tale of transforming growth factor-beta (TGFbeta) signaling: a soigne enigma. IUBMB Life 61: 929-939, 2009.
7. Collaco JM, Cutting GR. Update on gene modifiers in cystic fibrosis. Curr Opin Pulm Med 14: 559-566, 2008.
8. Contri A, Gloria A, Robbe D, Valorz C, Wegher L, Carluccio A. Kinematic study on the effect of pH on bull sperm function. Anim Reprod Sci 136: 252-259, 2013.
9. Corvol H, Boelle PY, Brouard J, Knauer N, Chadelat K, Henrion- Caude A, Flamant C, Muselet-Charlier C, Boule M, Fauroux B, Vallet C, Feingold J, Ratjen F, Grasemann H, Clement A. Genetic variations in inflammatory mediators influence lung disease progression in cystic fibrosis. Pediatr Pulmonol 43: 1224-1232, 2008.
10. Cuppens H, Cassiman JJ. CFTR mutations and polymorphisms in male infertility. Int J Androl 27: 251-256, 2004.
11. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425: 577-584, 2003.
12. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353: 1443-1453, 2005.
13. Frank J, Roux J, Kawakatsu H, Su G, Dagenais A, Berthiaume Y, Howard M, Canessa CM, Fang X, Sheppard D, Matthay MA, Pittet JF. Transforming growth factor-beta1 decreases expression of the epithelial sodium channel alphaENaC and alveolar epithelial vectorial sodium and fluid transport via an ERK1/2-dependent mechanism. J Biol Chem 278: 43939-43950, 2003.
14. Halder SK, Beauchamp RD, Datta PK. A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers. Neoplasia 7: 509-521, 2005.
15. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265: 808-811, 1994.
16. Harris WT, Muhlebach MS, Oster RA, Knowles MR, Clancy JP, Noah TL. Plasma TGF-beta(1) in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy. Pediatr Pulmonol 46: 688-695, 2011.
17. Havasi V, Rowe SM, Kolettis PN, Dayangac D, Sahin A, Grangeia A, Carvalho F, Barros A, Sousa M, Bassas L, Casals T, Sorscher EJ. Association of cystic fibrosis genetic modifiers with congenital bilateral absence of the vas deferens. Fertil Steril 94: 2122-2127.
18. Howe K, Gauldie J, McKay DM. TGF-β effects on epithelial ion transport and barrier: reduced Cl secretion blocked by a p38 MAPK inhibitor. Am J Physiol Cell Physiol 283: C1667-C1674, 2002.
19. Howe KL, Wang A, Hunter MM, Stanton BA, McKay DM. TGFbeta downregulation of the CFTR: a means to limit epithelial chloride secretion. Exp Cell Res 298: 473-484, 2004.
20. Ingman WV, Robertson SA. The essential roles of TGFB1 in reproduction. Cytokine Growth Factor Rev 20: 233-239, 2009.
21. Ingman WV, Robertson SA. Transforming growth factor-beta1 null mutation causes infertility in male mice associated with testosterone deficiency and sexual dysfunction. Endocrinology 148: 4032-4043, 2007.
22. Ishiguro H, Yamamoto A, Nakakuki M, Yi L, Ishiguro M, Yamaguchi M, Kondo S, Mochimaru Y. Physiology and pathophysiology of bicarbonate secretion by pancreatic duct epithelium. Nagoya J Med Sci 74: 1-18, 2012.
23. Jakubiczka S, Bettecken T, Stumm M, Nickel I, Musebeck J, Krebs P, Fischer C, Kleinstein J, Wieacker P. Frequency of CFTR gene mutations in males participating in an ICSI programme. Hum Reprod 14: 1833-1834, 1999.
24. Kumar S, Jiang MS, Adams JL, Lee JC. Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogenactivated protein kinase. Biochem Biophys Res Commun 263: 825-831, 1999.
25. Laping NJ, Grygielko E, Mathur A, Butter S, Bomberger J, Tweed C, Martin W, Fornwald J, Lehr R, Harling J, Gaster L, Callahan JF, Olson BA. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 62: 58-64, 2002.
26. Laurenza A, Sutkowski EM, Seamon KB. Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action? Trends Pharmacol Sci 10: 442-447, 1989.
27. Lewis-Jones DI, Gazvani MR, Mountford R. Cystic fibrosis in infertility: screening before assisted reproduction: opinion. Hum Reprod 15: 2415-2417, 2000.
28. Li C, Naren AP. Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners. Pharmacol Ther 108: 208-223, 2005.
29. Li H, Ganta S, Fong P. Altered ion transport by thyroid epithelia from CFTR pigs suggests mechanisms for hypothyroidism in cystic fibrosis. Exp Physiol 95: 1132-1144, 2010.
30. Mannowetz N, Wandernoth PM, Wennemuth G. Glucose is a pHdependent motor for sperm beat frequency during early activation. PLoS One 7: e41030, 2012.
31. Nocera M, Chu TM. Characterization of latent transforming growth factor-beta from human seminal plasma. Am J Reprod Immunol 33: 282-291, 1995.
32. O'Riordan CR, Lachapelle AL, Marshall J, Higgins EA, Cheng SH. Characterization of the oligosaccharide structures associated with the cystic fibrosis transmembrane conductance regulator. Glycobiology 10: 1225-1233, 2000.
33. Okamura N, Tajima Y, Ishikawa H, Yoshii S, Koiso K, Sugita Y. Lowered levels of bicarbonate in seminal plasma cause the poor sperm motility in human infertile patients. Fertil Steril 45: 265-272, 1986.
34. Oppenheim JJ, Feldmann M, Durum SK. Cytokine Reference: a Compendium of Cytokines and Other Mediators of Host Defense. San Diego, CA: Academic, 2001.
35. Pierucci-Alves F, Akoyev V, Stewart JC 3rd, Wang LH, Janardhan KS, Schultz BD. Swine models of cystic fibrosis reveal male reproductive tract phenotype at birth. Biol Reprod 85: 442-451, 2011.
36. Pierucci-Alves F, Duncan CL, Lillich JD, Schultz BD. Porcine vas deferens luminal pH is acutely increased by systemic xylazine administration. Biol Reprod 82: 132-135, 2010.
37. Politch JA, Tucker L, Bowman FP, Anderson DJ. Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum Reprod 22: 2928-2935, 2007.
38. Pruliere-Escabasse V, Fanen P, Dazy AC, Lechapt-Zalcman E, Rideau D, Edelman A, Escudier E, Coste A. TGF-β1 downregulates CFTR expression and function in nasal polyps of nonCF patients. Am J Physiol Lung Cell Mol Physiol 288: L77-L83, 2005.
39. Roux J, Carles M, Koh H, Goolaerts A, Ganter MT, Chesebro BB, Howard M, Houseman BT, Finkbeiner W, Shokat KM, Paquet AC, Matthay MA, Pittet JF. Transforming growth factor beta1 inhibits cystic fibrosis transmembrane conductance regulator-dependent cAMP-stimulated alveolar epithelial fluid transport via a phosphatidylinositol 3-kinasedependent mechanism. J Biol Chem 285: 4278-4290, 2010.
40. Schultz BD, Singh AK, Devor DC, Bridges RJ. Pharmacology of CFTR chloride channel activity. Physiol Rev 79: S109-144, 1999.
41. Schultz BD, Takahashi A, Liu C, Frizzell RA, Howard M. FLAG epitope positioned in an external loop preserves normal biophysical properties of CFTR. Am J Physiol Cell Physiol 273: C2080-C2089, 1997.
42. Schulz S, Jakubiczka S, Kropf S, Nickel I, Muschke P, Kleinstein J. Increased frequency of cystic fibrosis transmembrane conductance regulator gene mutations in infertile males. Fertil Steril 85: 135-138, 2006.
43. Sedlacek RL, Carlin RW, Singh AK, Schultz BD. Neurotransmitterstimulated ion transport by cultured porcine vas deferens epithelium. Am J Physiol Renal Physiol 281: F557-F570, 2001.
44. Singh AK, Schultz BD, van Driessche W, Bridges RJ. Transepithelial fluctuation analysis of chloride secretion. J Cyst Fibros 3, Suppl 2: 127-132, 2004.
45. Steward MC, Ishiguro H, Case RM. Mechanisms of bicarbonate secretion in the pancreatic duct. Annu Rev Physiol 67: 377-409, 2005.
46. Tajima Y, Okamura N. The enhancing effects of anion channel blockers on sperm activation by bicarbonate. Biochim Biophys Acta 1034: 326-332, 1990.
47. Taussig LM, Lobeck CC, di Sant'Agnese PA, Ackerman DR, Kattwinkel J. Fertility in males with cystic fibrosis. N Engl J Med 287: 586-589, 1972.
48. van der Ven K, Messer L, van der Ven H, Jeyendran RS, Ober C. Cystic fibrosis mutation screening in healthy men with reduced sperm quality. Hum Reprod 11: 513-517, 1996.
49. Wangemann P, Itza EM, Albrecht B, Wu T, Jabba SV, Maganti RJ, Lee JH, Everett LA, Wall SM, Royaux IE, Green ED, Marcus DC. Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model. BMC Med 2: 30, 2004.
50. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD. p38 MAPK activation elevates serotonin transport activity via a traffickingindependent, protein phosphatase 2A-dependent process. J Biol Chem 280: 15649-15658, 2005.